Old Web
English
Sign In
Acemap
>
authorDetail
>
Kevin Murray Schaab
Kevin Murray Schaab
5-lipoxygenase-activating protein
Area under the curve
Leukotriene
Pharmacodynamics
Anesthesia
4
Papers
51
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitor.
2013
British Journal of Clinical Pharmacology
Gretchen Bain
Christopher D. King
Kevin Murray Schaab
Melissa Rewolinski
Virginia Norris
Claire Ambery
Jane Bentley
Masanori Yamada
Angelina M. Santini
Jeroen van de Wetering de Rooij
Nicholas Simon Stock
Jasmine Zunic
John H. Hutchinson
Jilly F. Evans
Show All
Source
Cite
Save
Citations (17)
5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)—A potent FLAP inhibitor suitable for topical administration
2010
Bioorganic & Medicinal Chemistry Letters
Nicholas Simon Stock
Christopher Baccei
Gretchen Bain
Charles Chapman
Lucia Correa
Janice Darlington
Christopher King
Catherine Lee
Daniel S. Lorrain
Pat Prodanovich
Angelina Santini
Kevin Murray Schaab
Jilly F. Evans
John H. Hutchinson
Peppi Prasit
Show All
Source
Cite
Save
Citations (10)
1